Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Geologica Closes Financing And Property Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Achieve Life Sciences Inc ACHV

Healthcare Biotechnology
Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a well-defined, dual-acting mechanism of... see more

Recent & Breaking News (NDAQ:ACHV)

30 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  September 27, 2018

Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects

PR Newswire September 27, 2018

Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018

PR Newswire September 26, 2018

Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy

PR Newswire September 18, 2018

Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference

PR Newswire September 6, 2018

Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018

PR Newswire September 5, 2018

Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update

PR Newswire August 8, 2018

Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018

PR Newswire August 2, 2018

Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA

PR Newswire July 11, 2018

Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction

PR Newswire June 26, 2018

Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

PR Newswire June 19, 2018

Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering

PR Newswire June 15, 2018

Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules

PR Newswire June 11, 2018

Achieve Reports Financial Results for First Quarter 2018

PR Newswire May 9, 2018

Benzinga Pro's 5 Stocks To Watch Today

Benzinga.com  May 7, 2018

Achieve Announces Patent Granted on Novel Formulation of Cytisine

PR Newswire May 7, 2018

Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health

PR Newswire March 6, 2018

Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results

PR Newswire March 1, 2018

Mid-Day Market Update: Fogo De Chao Gains On Acquisition News; Ubiquiti Networks Shares Slide

Benzinga.com  February 20, 2018

Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study

PR Newswire February 20, 2018